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A simple, rapid and precise HPLC method has been developed for the assay of verapamil in human plasma. The clean up of the plasma samples was
tested using several adsorbents for solid-phase extraction and best recovery was obtained using mixed-mode cartridges (HLB - hydrophilic-lipophilic
balance) ranging between 94.70 and 103.71%. HPLC separation was performed with isocratic elution on Lichrospher 60 RP-select B column (250 mm ×
4mmI.D., 5μmparticle size). Themobile phasewas 40%acetonitrile and 0.025mol/LKH2PO4with pH2.5 at flow rate of 1mL/min.Diltiazemwas used as
internal standard and the detection wavelength was 200 nm. The calibration curves were linear in the range of 10–500 ng/mL. The developed method is
convenient for routine analysis of verapamil in human plasma.
© 2007 Elsevier B.V. All rights reserved.Keywords: Verapamil; Human plasma; Solid-phase extraction; HPLC1. Introduction
Verapamil is a calcium blocker (Fig. 1) with a widespread
use in management of supraventricular tachyarrhythmias,
angina pectoris, hypertrophic cardiomyopathy and hypertension
[1]. It is mostly used in a conventional tablet form in doses
ranging from 40 to 180 mg and in a slow release form in doses
of 120 and 240 mg.
About 90% of orally introduced verapamil is absorbed in the
digestive tract, but only 10–20% of the dose enters the
circulatory system unchanged. The biological half-time of
verapamil is 3–7 h and the therapeutic concentrations of the
drug in human plasma range from 20–500 ng/mL. Verapamil is
metabolized mainly in human liver to six (according to some
authors to twelve) metabolites, which are excreted through the
kidneys. Only norverapamil, the N-demethylated metabolite, is
pharmacologically active [2]. It shows about 20% of the
efficacy of verapamil with regard to the vasodilatation effect,
but has not antiarrhythmic activity.☆ Dedicated to Academician Bojan Soptrajanov, the leader of the Spectros-
copy Group in Macedonia, on the occasion of his 70th birthday.
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doi:10.1016/j.jbbm.2007.09.009Many investigations have been performed for determination
of verapamil in human plasma using high-performance liquid
chromatography (HPLC) with various detection systems. Some
of them employ fluorescence detection [3–10], very few
employ spectrophotometric detection in the UV range [11,12],
whereas mass spectrometric detection is used in the recent
developed methods [13–17].
As for the sample preparation procedures employed prior to
the HPLC determination of verapamil, there is a diversity in the
speed and complexity of the clean-up methods starting from
direct determination of verapamil from rat plasma [7], through
using only deproteinization of the plasma samples [11,13] to the
more complex ones such as liquid–liquid extraction (LLE)
using various organic solvents [3,4,6,9,10,15] and solid-phase
extraction (SPE) with various adsorbents [4,8,9,17]. The most
sophisticated sample preparation procedures employ automated
column switching techniques for on-line sample preparation
[5,7,8,12]. The efficiency of the liquid–liquid extraction and
automated liquid–solid extraction has been compared by
Hubert et al. [4] who found better sensitivity and precision of
the liquid–solid extraction, but still recommended the liquid–
liquid procedure as useful alternative. SPE using C18 SepPak
cartridges was used for extraction of verapamil and its meta-
bolites in serum samples (recovery: 87.7 ± 5.8 to 92.7 ± 4.0%)
Fig. 1. Structure of verapamil.
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to 98.25%) [8]. Verapamil and norverapamil in blood, liver
and kidney using HPLC with fluorescence detection with prior
LLE and SPE with C2 silica phases has been used and the
LLE procedure proved to be simpler, less expensive and more
versatile than SPE especially for complex biological speci-
mens such as tissue samples [9]. A sample preparation pro-
cedure employing SPE with a mixed-mode sorbent (reversed
phase and cation exchanger) has been developed for the
determination of 14 drugs in whole blood including verapamil
with high recoveries for most of them (N 96% fro verapamil)
[17].
The purpose of this study was to develop a solid-phase
extraction method for extraction of verapamil from human
plasma and develop and validate a chromatographic method
with UV detection suitable for the determination of the inves-
tigated drug. The sample preparation procedure was developed
by testing several types of adsorbents and HLB cartridges were
found to give best results for separation and concentration of
verapamil from plasma. This is a very convenient method for
separation and concentration of the analyzed drug and elimi-
nation of plasma interferences, because of its efficiency and
rapid sample preparation. The method was validated by evalua-
ting the recovery, selectivity, linearity, precision and accuracy.
Finally, the method was used for determination of verapamil in
real plasma samples from patients.
2. Materials and methods
2.1. Reagents and materials
Verapamil and the internal standard (I.S.), diltiazem, were
kindly provided from Knoll GmbH (Ludwigshafen, Germany)
and De Graaf sa (Lugano, Switzerland), respectively. Acetoni-
trile, methanol, phosphoric acid and potassium dihydrogen
phosphate were purchased from Merck (Darmstadt, Germany).
All reagents used were HPLC grade. The used HPLC column
was Lichrospher 60 RP-select B (250mm × 4mm I.D., 5 μm
particle size) from Merck and cartridges used for solid-phase
extraction were LiChrolut RP-18 (Merck), TSC (Merck),
ENVI-Carb (Supelco) and Oasis HLB (Waters).
2.2. Preparation of standard solutions and calibration
Stock solutions of verapamil and diltiazem were prepared at
concentrations of 1mg/mL by dissolving appropriate amounts of
verapamil hydrochloride and diltiazem hydrochloride in water.
The working solutions were prepared by diluting appropriate
portions of these solutions with distilled water.Calibration curves were constructed with five blank plasma
samples spiked with appropriate amounts of the standard sol-
utions. Linear regression analysis was performed. The calibra-
tion range was 10–500 ng/mL of verapamil for plasma, while
the three control standards contained 25, 150 and 300 ng/mL
verapamil in blank plasma.
2.3. Instrumentation and HPLC analysis
Analysis of verapamil was carried out using a Varian HPLC
system equipped with a ternary pump Model 9012 and UV
Diode Array Detector Model 9065. Different column packing
including C18 and RP-select B were tested. The final choice,
giving satisfying peak shape, resolution and run time was a
Lichrospher 60 RP-select B column (250mm × 4 mm I.D., 5 μm
particle size) with the analogous guard column (4 mm × 4 mm,
5 μm particle size). The mobile phase consisting of 0.025 mol/L
KH2PO4, pH 2.5 and acetonitrile in ratio 60:40 (V/V) was found
to give best results. Isocratic elution was performed with a flow
rate of 1 mL/min at ambient temperature. Elution was
monitored in the whole UV region and the best detection was
achieved at 200 nm. Separation of the analyzed drug was
performed with the solid-phase extraction manifold Visiprep™
from Supelco.
2.4. Sample preparation
Human plasma was prepared from heparinized whole-blood
samples. Blood samples were collected from healthy volunteers
and stored at −20°C. After thawing, samples were spiked daily
with working solutions of verapamil and internal standard,
diltiazem.
A set of cartridges with different stationary phases for SPE
were tested: LiChrolut RP-18 (Merck), TSC (Merck), ENVI-
Carb (Supelco) and Oasis HLB (Waters). The best results for
isolation of verapamil and I.S. were obtained when extraction
was performed with Oasis HLB cartridges using the following
procedure.
Before extraction, plasma samples were buffered with 1 mL
of 0.1 mol/L KH2PO4 solution with pH 9 and 1 mL of prepared
samples were spiked with 50 μL of internal standard, diltiazem.
The cartridges were conditioned with 1 mL methanol and 1 mL
water. The buffered plasma was introduced into the cartridge.
1 mL solution of 65% methanol with 2% NH4OH was used to
rinse the cartridge and remove the interferential components.
Elution was performed with 1 mL solution of 65% methanol
with 2% acetic acid. The eluate was evaporated to dryness under
air for about 30 min at 40 - 45°C and the residue was dissolved
in 200 μL mobile phase. 100 μL of the final solution was
injected into the HPLC system.
3. Results
Several HPLCmethod variables with respect to their effect on
the place and shape of the peaks of verapamil and internal
standard, diltiazem, were tested: HPLC columns with different
bonded phases (C18 and RP-select B), series of mobile phases
Fig. 2. Effect of: a) acetonitrile content, b) buffer concentration, and c) pH of the
mobile phase on retention.
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mobile phase, the effect of buffer concentration, the effect of
mobile phase pH, the effect of iso-propanol in the buffer solution
and the effect of temperature on retention and resolution of
analyzed component and internal standard. According to the
obtained data, satisfactory resolution and relatively short
analysis time were obtained when separation was performed
on Lichrospher 60 RP-select B column (250 mm × 4 mm I.D.,
5 μm particle size) protected with appropriate guard column at
ambient temperature, using the optimal mobile phase consisting
of 40% (V/V) acetonitrile in 0.025mol/LKH2PO4 buffer, pH 2.5.
The flow rate on the mobile phase was 1 mL/min and detection
of verapamil and internal standard diltiazem was performed on
wavelength of 200 nm. The retention times of verapamil and
internal standard, diltiazem were 4.2 and 5.6 min respectively.
Several types of cartridges for solid-phase extraction [TSC
(Merck), LiChrolut RP-18 (Merck), ENVI-CARB (Supelco) и
Oasis HLB (Waters)] were tested in order to obtain satisfactory
values for the recovery of verapamil and the internal standard
(diltiazem). In order to achieve good separation of verapamil and
I.S. from the plasma matrix, different parameters were checked:
dilution and buffering of the samples, washing solutions, pH and
the composition of the elution solvents. The best purification and
satisfied recovery values for verapamil were obtained using
HLB columns, preparing the samples with 0.1 mol/L KH2PO4
(pH 9). Extraction recoveries for verapamil using HLB columns
were satisfactory ranging from 94.70–103.71% and these
cartridges were used for all investigations in this study.
3.1. Method development
In order to develop a convenient, simple and accurate HPLC
method for quantitative determination of verapamil in human
plasma with internal standard, diltiazem, several investigations
were performed. Diltiazem was chosen as internal standard
because of its good response at the working wavelength and not
interfering in the analysis of verapamil. It is chemically stable
and similar with the analyzed component; verapamil and the
reverse combination (diltiazem, as analyzed substance and ve-
rapamil, as internal standard) has already been used in a vali-
dated method [18].
A set of HPLC columns with different bonded phases (C18
and RP-select B) were tested in our preliminary experiments.
Symmetrical peak shapes, satisfactory resolution and relatively
short analysis time were obtained when separation was
performed on Lichrospher 60 RP-select B column (250 mm ×
4 mm I.D., 5 μm particle size) protected with appropriate guard
column. All investigations were performed with 1 mL/min flow
rate on the mobile phase. The elution was monitored in the
whole UV region and the wavelength of 200 nm was chosen for
detection of verapamil and internal standard diltiazem because
of the highest sensitivity.
Series of mobile phases with different amount of organic
modifier acetonitrile present in the mobile phase were tested to
investigate its effect on separation of verapamil and diltiazem. In
Fig. 2a the results obtained by elution with acetonitrile present in
the range from 30 to 60% are presented. Satisfactory resolutionand analysis time were obtained when using 40% (V/V)
acetonitrile in the mobile phase.
The effect of buffer concentration on analyte retention and
separation was also tested in the concentration range from 0.01
to 0.1 mol/L. The buffer concentration of 0.025 mol/L KH2PO4
(Fig. 2b) was chosen because the subsequent increasing of
concentration did not cause significant changes on retention
times of the components and peak shapes.
The effect of mobile phase pH on analyte retention and the
shape of analyte peaks was tested as well. The obtained results
showed a relatively long analysis time and poor separation when
using a mobile phase with pH = 6.0. When decreasing the pH
value, separation improved and best resolution between two
peaks and short analysis time was obtained with a mobile phase
with pH = 2.5. The results are shown in Fig. 2c.
Additionally, the effect of iso-propanol added in the buffer
solution was tested in the range from 0.5 to 4%. This test was
Fig. 3. Chromatogram of standard solutions of verapamil (10 μg/mL) and
internal standard diltiazem (10 μg/mL), (D-diltiazem, V-verapamil).
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modifier in the method for determination of diltiazem in human
plasma using verapamil as internal standard [18]. The presence
of iso-propanol in the mobile phase did not improve the analyte
resolution and peak shape, but on the contrary, it caused distor-
tion and tailing of the analyte peaks. Therefore, the further
analyses were performed using mobile phase without iso-
propanol.
Finally, the effect of temperature on retention and resolution
of analyzed component and internal standard in range from 20 toFig. 4. Chromatograms of plasma samples prepared with different solvents and obtain
and 2-KH2PO4 (pH 9). b. Samples prepared on ENVI-Carb with 0.01mol/L KH2P
d. Samples prepared on HLB with: 1-H3PO4 and 2-KH2PO4 (pH 9).50°C was tested. The obtained results showed that temperature
does not have a significant effect on peaks shape and the
analysis time is negligible shorten. So, ambient temperature was
chosen for all further investigations.
From these data, the following optimal mobile phase was
established: 40% (V/V) acetonitrile in 0.025 mol/L KH2PO4
buffer, pH 2.5. The retention times of verapamil and internal
standard, diltiazem were 4.2 and 5.6 min respectively. Typical
chromatograms obtained from standard solution of verapamil
and diltiazem produced by the developed HPLC method are
shown in Fig. 3. These conditions were applied on the plasma
samples after the SPE procedure and the peaks of verapamil and
diltiazem were well separated from the matrix components
remained after the sample preparation procedure.
For determination of the analytical recovery of the sample
preparation procedure, a calibration diagram was constructed
using aqueous standard solutions. The obtained linear depen-
dence peak area of verapamil/peak area of diltiazem with
correlation coefficient (0.9987) is the following:
AreaðVÞ=AreaðDÞ ¼ 0:008721  g Dð Þ ng=mL½  þ 0:166907
The extraction recoveries were calculated by comparing the
peak area of verapamil and internal standard obtained after solid-ed after SPE on different cartridges. a. Samples prepared on TSC with: 1-H3BO3
O4: 1-pH 6 and 2-pH 3. c. Samples prepared on RP-18 with KH2PO4 (pH 9).
Fig. 5. Chromatograms of 1-blank plasma, 2 - spiked plasma containing 300 ng/
mL verapamil and 250 ng/mL diltiazem, and 3 -blood sample containing 23 ng/mL
verapamil (D-diltiazem, V-verapamil).
Table 2
Intra- and Inter- day accuracy and precision data for verapamil in human plasma
determined after solid-phase extraction








Intra-day accuracy and precision data for verapamil
1 26.31 5.24 147.34 −1.77 310.91 3.64
2 24.52 −1.92 145.78 −2.81 295.34 −1.55
3 24.38 −2.48 153.67 2.45 312.18 4.06
bxN 25.07 0.28 148.93 −0.71 306.14 2.05
sd 1.07 4.18 9.38
RSD (%) 4.29 2.81 3.06
Inter-day accuracy and precision data for verapamil
I/1 24.23 −3.08 157.11 4.74 316.8 5.60
I/2 25.57 2.28 145.78 −2.81 276.76 −7.74
II/1 24.82 −0.72 146.25 −2.50 309.47 3.16
II/2 23.15 −7.40 151.40 0.93 288.44 −3.85
III/1 26.06 4.24 156.65 4.43 306.07 2.02
III/2 24.36 −2.56 150.93 0.62 293.83 −2.06
bxN 24.69 −1.21 151.35 0.90 298.56 −0.48
sd 1.04 4.87 14.89
RSD (%) 4.19 3.22 4.98
Table 3
Limit of quantification of verapamil
1301V. Ivanova et al. / J. Biochem. Biophys. Methods 70 (2008) 1297–1303phase extraction and those resulting from the direct injection of
aqueous standard solutions of verapamil and internal standard.
4. Discussion
4.1. SPE optimization
The testing of the SPE cartridges [TSC (Merck), LiChrolut
RP-18 (Merck), ENVI-CARB (Supelco) and Oasis HLB
(Waters)] was performed for establishing the conditions for
obtaining satisfactory values for the recovery of verapamil and
the internal standard, diltiazem. The influence of the dilution and
buffering of samples, washing solutions, pH and the composi-
tion of the elution solvents was checked for all cartridges and
Oasis HLB with mixed-mode stationary phase gave most satis-
factory results.
TSC columns were found to be not convenient for extraction
of verapamil from plasma and poor results were obtained when
this type of cartridges was used for solid-phase extraction. Peaks
of verapamil and I.S. had tailing and were not suitable for
quantification (Fig. 4a). ENVI-Carb columns were also not
convenient for efficient extraction of verapamil. Despite all
efforts, the loss of analyte and internal standard was noticed
during the washing step (Fig. 4b).
One of the most commonly used cartridges for SPE, RP-18
columns, were also tested for extraction of verapamil.
Brandsteterova and Wainer [8] have used C18 SepPak cartridges
for extraction of verapamil and its metabolites in serum samples
(recovery: 87.7 ± 5.8 to 92.7 ± 4.0%). However, in our case,
purification of the plasma samples and complete separation of
verapamil with RP-18 columns was not attained because the
interferences were adsorbed and coeluted with the analyte andTable 1
Results for intercept, slope and R2 of the calibration curve for the linearity test
Day Intercept Slope R2
1 0.00456 0.18847 0.9996
2 0.00494 0.19746 0.9995
3 0.01006 0.22193 0.9997good chromatographic separation of the peak of verapamil and
the abutting peaks of the interferential components was not
achieved (Fig. 4c). This may explain the poor data in the lite-
rature for employing this most universally used adsorbent for
preparation of biological samples for determination of
verapamil.
Efficient purification and satisfied recovery values for
verapamil were obtained using HLB columns, preparing the
samples with concentrated H3PO4 (20 μL were added in 1ml
sample) and 0.1mol/L KH2PO4 (pH 9). The obtained chromato-
graphic peaks of verapamil and diltiazem are sharp, symmetrical
and well separated from the matrix components present in the
plasma (Fig. 4d). Extraction recoveries for verapamil using HLB
columns were satisfactory ranging from 94.70–103.71% and
these cartridges were used for all investigations in this study.
The developed HPLCmethodwas used for analysis of patient
plasma samples after oral administration of verapamil. Typical
chromatogram obtained from plasma samples of patients
prepared according to the developed procedure for sample
preparation after a single oral dose of verapamil is shown in










Stability of verapamil in human plasma
Analyzed samples 25.0 ng/mL er (%) 300.0 ng/mL er (%)
Immediately 26.29 5.16 301.74 0.58
After 2 h 27.18 3.38 313.38 3.86
After 24 h 25.74 −2.09 293.14 −2.85
Cycle 1 27.45 4.41 309.61 2.61
Cycle 2 24.97 −5.02 284.15 −5.82
After 1 month 26.38 0.34 308.09 2.10
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4.2.1. Linearity
Linearity was tested in 3 days at five concentration levels
ranging from 10–500 ng/mL of verapamil and concentration of
250 ng/mL of internal standard, diltiazem in plasma samples.
Slope, intercept, and correlation coefficient were calculated and
the results are presented in Table 1.
4.2.2. Accuracy and precision
Intra- and inter-day accuracy was determined by measuring
plasma quality control samples at low (25 ng/mL), medium
(150 ng/mL) and high (300 ng/mL) concentration levels of
verapamil. Concentration of internal standard in spiked plasma
was 250 ng/mL. An indication of accuracy was based on
calculation of the relative error of the mean observed concentra-
tion compared to the nominal concentration. Precision was ex-
pressed as relative standard deviation (RSD). Obtained results are
presented in Table 2.
Relative errors were found to be between 0.72 and 7.74%, and
relative standard deviation between 2.81 to 4.98%. The obtained
results indicated satisfactory precision and accuracy of the pro-
posed method.
4.2.3. Limit of quantification (LOQ)
Limit of quantification was accepted as the lowest concen-
tration of verapamil which can be measured with an error less
than 20%. It was determined using the lowest calibration
standard in five different analytical days. Verapamil concentra-Table 5
Ruggedness of the method for verapamil determination using mobile phases with d
Sample pH 2.5 pH 2.2 pH 2.8
Area Area er (%) Area er (%)
Verapamil
1 60485 62540 3.39 62564 3.44
2 61019 61774 1.24 63672 4.35
3 60596 65166 7.54 63598 4.95
4 61619 64176 4.15 64142 4.09
bXN 61429.7 63414 4.08 63494 4.21
Diltiazem
1 42338 44158 4.29 43241 2.13
2 45073 42954 −4.70 46136 2.36
3 44831 46475 3.67 45767 2.08
4 45204 45498 0.65 46512 2.89
bXN 44361.5 44771.2 0.98 45414 2.37tion of 10 ng/mL was accepted as LOQ. Results are presented in
Table 3.
4.2.4. Stability of verapamil in plasma samples
Stability of verapamil in plasma samples was investigated
with spiked samples at two different concentration levels
prepared in duplicate. Spiked samples were analyzed after
different storage conditions: immediately, after staying for 2 and
24 hours at room temperature, after one and two freeze/thaw
cycles and after 1 month stored at −20°C. The obtained results
are shown in Table 4 and show that relative errors are between
0.58 and 5.82%, which confirm the stability of verapamil in
plasma samples under different storage conditions.
4.2.5. Ruggedness of the method
Ruggedness of the method was checked by applying the
proposed HPLC method with mobile phases with different pH
values and detection at different wavelengths. Relative error was
calculated by comparing pH value of the mobile phase from 2.2
to 2.8 or to those obtained by changing the detection wavelength
from 195 to 205 nm. Standard solution with medium
concentration of the analyzed component (500 ng/mL verapamil
spiked with 250 μg/mL internal standard) was directly injected
into the HPLC system. Results presented in Table 5 show
relative errors less than 4.7% indicating good ruggedness of the
developed HPLC method at different values of pH of the mobile
phase. On the other hand, changing of wavelengths in the range
of 195–205 nm produces high relative errors for verapamil
because of the considerable change of the absorbance with
wavelength in this narrow region. These results clearly indicate
that analysis of the investigated drug must be performed every
time at wavelength of 200 nm. The relative errors for the internal
standard, diltiazem, are in permissive range between 0.07–4.8%.
5. Conclusion
The developed HPLC method including solid-phase extrac-
tion for sample preparation is simple, rapid and convenient for
determination of verapamil in plasma samples. Different
cartridges for SPE were tested and the best results wereifferent pH values and determination at different detection wavelengths
200 nm 195 nm 205 nm
Area Area er (%) Area er (%)
60485 51713 −14.50 40954 −32.29
61019 53962 11.56 39865 −34.67
62596 45197 −27.79 40132 −35.88
61619 52932 −14.09 38231 −37.95
61429.7 50951 −16.99 39795.5 −34.20
42338 44104 4.17 41425 −2.15
45073 47105 4.51 45112 0.08
44831 47005 4.85 44866 0.07
45204 47179 4.37 45173 −0.06
44361.5 46348.2 4.47 44144 −0.52
1303V. Ivanova et al. / J. Biochem. Biophys. Methods 70 (2008) 1297–1303achieved using HLB columns. The optimized SPE conditions
for separation of verapamil with HLB cartridges provide ef-
ficient clean up of the complex biological matrix and high
recovery of the investigated drug. Parameters of validation
demonstrate good precision and accuracy, which proves the
reliability of the proposed method. Finally, this method is sui-
table for identification and quantification of verapamil in human
plasma and it can be useful in pharmaceutical studies.
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